InvestorsHub Logo
Followers 25
Posts 570
Boards Moderated 0
Alias Born 06/11/2011

Re: kabunushi post# 698673

Monday, 06/17/2024 6:30:36 AM

Monday, June 17, 2024 6:30:36 AM

Post# of 716341
It is incorrect to say that NICE has to evaluate treatments before they can be marketed. NICE's job is to evaluate the efficacy of a treatment to decide whether it should be included in the NHS's list of treatments that can be prescribed and paid for on the NHS.
If the MHRA licences a treatment but NICE decides that the treatment is too expensive for the benefit provided, patients in the UK will still be able to receive the treatment but they will have to cover the financial costs themselves.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News